Kinetic parameters of alpha-synuclein seed amplification assay correlate with cognitive impairment in patients with Lewy body disorders

MLA

Stefan Bräuer, et al. “Kinetic Parameters of Alpha-Synuclein Seed Amplification Assay Correlate with Cognitive Impairment in Patients with Lewy Body Disorders.” Acta Neuropathologica Communications, vol. 11, no. 1, Oct. 2023, pp. 1–9. EBSCOhost, https://doi.org/10.1186/s40478-023-01653-3.

APA

Stefan Bräuer, Marcello Rossi, Johann Sajapin, Thomas Henle, Thomas Gasser, Piero Parchi, Kathrin Brockmann, & Björn H. Falkenburger. (2023). Kinetic parameters of alpha-synuclein seed amplification assay correlate with cognitive impairment in patients with Lewy body disorders. Acta Neuropathologica Communications, 11(1), 1–9. https://doi.org/10.1186/s40478-023-01653-3

Chicago

Stefan Bräuer, Marcello Rossi, Johann Sajapin, Thomas Henle, Thomas Gasser, Piero Parchi, Kathrin Brockmann, and Björn H. Falkenburger. 2023. “Kinetic Parameters of Alpha-Synuclein Seed Amplification Assay Correlate with Cognitive Impairment in Patients with Lewy Body Disorders.” Acta Neuropathologica Communications 11 (1): 1–9. doi:10.1186/s40478-023-01653-3.